Advanced Proteome Therapeutics Corp (APC)

0.07
-0.01(-7.14%)
  • Volume:
    23,500
  • Bid/Ask:
    0.07/0.09
  • Day's Range:
    0.07 - 0.07
Trading near 52-week Low

Advanced Proteome has hit the lowest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

APC Overview

Prev. Close
0.07
Day's Range
0.07-0.07
Revenue
-
Open
0.07
52 wk Range
0.07-0.32
EPS
0.026
Volume
23,500
Market Cap
2.78M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
66,549
P/E Ratio
2.93
Beta
1.08
1-Year Change
-73.08%
Shares Outstanding
39,677,080
Next Earnings Date
-
What is your sentiment on Advanced Proteome?
or
Market is currently closed. Voting is open during market hours.

Advanced Proteome Therapeutics Corp News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Advanced Proteome Therapeutics Corp Analysis

Advanced Proteome Therapeutics Corp Company Profile

Advanced Proteome Therapeutics Corp Company Profile

Employees
0
Market
Canada
  • Type:Equity
  • Market:Canada
  • ISIN:CA0076282098
  • CUSIP:007628209

Advanced Proteome Therapeutics Corporation is a biotechnology company, which is focused on developing and commercializing a platform that is intended to use advanced protein modification technologies to create human protein pharmaceuticals with enhanced therapeutic properties. The Company, through its subsidiary, Advanced Proteome Therapeutics Inc., has invented protein conjugation technology, which enables the development of antibody-drug conjugates through improved site-specific labeling, drug-antibody ratio control and enabling of combination payloads. The technology has pre-clinical data demonstrating improved homogeneity and increased in-vivo potency relative to linker technology. Its work allows cancer drugs to be produced and delivered to cancerous tumors by standardizing the production of antibody drug conjugates to treat cancer, using site-selective chemistries as protein modification technologies.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell